Mission and Vision
Founded in 2017, the Androgen Society is an international medical and scientific society dedicated to the study of androgens, in particular testosterone deficiency (hypogonadism) and its treatment.
Our mission is to promote education, research, and training, bringing together experts and interested individuals from all disciplines within medicine, including endocrinology, urology, general medicine, sexual medicine, and epidemiology, among others.
Testosterone deficiency, also known as hypogonadism, is a common medical condition that affects male health and quality of life. Treatment effectively improves symptoms and health in many men. Although a number of medical and scientific disciplines have historically addressed testosterone-related issues, the field has unfortunately been fragmented, and experts from one field rarely interact with experts from other fields.
The primary goal of the Androgen Society is to provide a “home” for individuals from all backgrounds and training to come together for an annual meeting, to discuss new and exciting research, as well as existing medical practices that often vary from one medical specialty to another.
Our annual meeting is intended to enhance-not compete with- the training and education provided at existing professional meetings. This opportunity is unique within the health sciences.
Androgen Society Board
Hugh Jones, MD (UK)
Abdulmaged M. Traish, MBA, PhD (USA)
Michael Zitzmann, MD, PhD (Germany)
Martin Miner, MD (USA)
Immediate Past President
Abraham Morgentaler, MD (USA)
Adrian S. Dobs, MD, MHS (USA)
Wayne J. G. Hellstrom, MD, FACS (USA)